Latest filing published 28 Dec 2016 for Sonnet BioTherapeutics Holdings, Inc., €1,290.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Daniel Roberson: trading record in brief
Mark Daniel Roberson has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Pokertek Inc and Sonnet BioTherapeutics Holdings, Inc. The record holds 21 filings, for trades running from 16 November 2007 to 28 December 2016.
The open-market record is one-sided, with 14 purchases worth €74k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants. In 2016 alone, the filings show 2 purchases and no sales.
In size, the median ticket on the buying side is €1,425.
The latest filing, published on 28 December 2016, reports an open-market purchase of €1,290 in Sonnet BioTherapeutics Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Daniel Roberson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$13.5061.0% of flowSeries 1 Preferred StockSEC:0001493152-16-016225:0Canonical exit: 28 Mar 2017 (T+90)
- 2,000 shares@ US$0.4339.0% of flowCommon StockSEC:0001493152-16-016062:0Canonical exit: 20 Mar 2017 (T+90)
- 300,000 sharesCommon StockSEC:0001445866-14-000084:0
- 14,545 shares@ US$1.15Common StockSEC:0001445866-13-001130:0
- 17,172 shares@ US$1.36Common StockSEC:0001445866-13-000804:0
- 4,000 shares@ US$1.08Common StockSEC:0001140361-12-052772:0Canonical exit: 26 Mar 2013 (T+90)
- 29,855 shares@ US$0.85Common StockSEC:0001140361-12-049323:0
- 15,000 shares@ US$0.73Common StockSEC:0001140361-12-049323:3Canonical exit: 28 Feb 2013 (T+90)
- 15,194 shares@ US$0.97Common StockSEC:0001140361-12-049323:1
- 12,921 shares@ US$0.76Common StockSEC:0001140361-12-049323:2
- 225,000 sharesCommon StockSEC:0001140361-11-047835:0
- 25,735 shares@ US$1.36Common StockSEC:0001140361-11-027761:0Canonical exit: 10 Aug 2011 (T+90)
- 2,500 shares@ US$0.7075Common StockSEC:0001140361-11-000734:0Canonical exit: 31 Mar 2011 (T+90)
- 2,500 shares@ US$0.719Common StockSEC:0001140361-11-000734:1Canonical exit: 31 Mar 2011 (T+90)
- 2,000 shares@ US$0.63Common StockSEC:0001140361-10-036125:0Canonical exit: 1 Dec 2010 (T+90)
- 2,000 shares@ US$0.55Common StockSEC:0001140361-10-035574:0Canonical exit: 25 Nov 2010 (T+90)
- 62,500 shares@ US$0.48Common StockSEC:0001140361-10-015563:0Canonical exit: 30 Jun 2010 (T+90)
- 4,000 shares@ US$0.50Common StockSEC:0001140361-10-015563:1Canonical exit: 5 Jul 2010 (T+90)
- 1,500 shares@ US$0.50Common StockSEC:0001140361-10-014544:0Canonical exit: 27 Jun 2010 (T+90)
- 1,000 shares@ US$3.50Common StockSEC:0001140361-08-018273:0Canonical exit: 30 Oct 2008 (T+90)
20 of 20 declarations